Literature DB >> 23161719

Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.

Young Wha Koh1, Hyo Jeong Kang, Chansik Park, Dok Hyun Yoon, Shin Kim, Cheolwon Suh, Ji Eun Kim, Chul-Woo Kim, Jooryung Huh.   

Abstract

The aim of this study was to determine the prognostic effect of the absolute neutrophil count/absolute lymphocyte count ratio (ANC/ALC ratio) in patients with classic Hodgkin lymphoma (cHL). We performed a retrospective analysis of 312 patients with cHL. Univariate analysis revealed that a high ANC/ALC ratio (≥4.3) correlated with poor overall survival (OS) (P < .001). Subgroup analysis of advanced-stage disease showed that the ANC/ALC ratio was significant for OS (P = .032). Multivariate analysis revealed the ANC/ALC ratio to be an independent prognostic factor for OS (P = .048). The ANC/ALC ratio allowed further risk stratification in patients who were considered to be at low risk on the basis of an International Prognostic Score less than 4 (P = .002). The ANC/ALC ratio is a simple, inexpensive, and independent prognostic factor for OS that may improve the ability to identify high-risk patients with cHL.

Entities:  

Mesh:

Year:  2012        PMID: 23161719     DOI: 10.1309/AJCPO46GFKGNXCBR

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  18 in total

1.  Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.

Authors:  Young Wha Koh; Hee Jin Lee; Jin-Hee Ahn; Jong Won Lee; Gyungyub Gong
Journal:  Tumour Biol       Date:  2014-07-02

Review 2.  Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.

Authors:  Adalgisa Condoluci; Davide Rossi; Emanuele Zucca; Franco Cavalli
Journal:  Curr Oncol Rep       Date:  2018-08-22       Impact factor: 5.075

3.  The Predictive Role of the Neutrophil/Lymphocyte Ratio in Survival with Multiple Myeloma: A Single Center Experience.

Authors:  Birgul Onec; Harika Okutan; Murat Albayrak; Esra Saribacak Can; Vedat Aslan; Basak Unver Koluman; Ozge Soyer Kosemehmetoglu; Aynur Albayrak; Durdu Mehmet Kos
Journal:  J Clin Lab Anal       Date:  2016-08-08       Impact factor: 2.352

4.  Prognostic role of neutrophil-lymphocyte ratio in multiple myeloma: a dose-response meta-analysis.

Authors:  Shidai Mu; Lisha Ai; Fengjuan Fan; Chunyan Sun; Yu Hu
Journal:  Onco Targets Ther       Date:  2018-01-23       Impact factor: 4.147

5.  Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma.

Authors:  Dae Sik Kim; Eun Sang Yu; Ka-Won Kang; Se Ryeon Lee; Yong Park; Hwa Jung Sung; Chul Won Choi; Byung Soo Kim
Journal:  Korean J Intern Med       Date:  2016-11-04       Impact factor: 2.884

6.  Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.

Authors:  Jin Wang; Xu Zhou; Yu Liu; Zheng Li; Xiang Li
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

7.  Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.

Authors:  Raffaella Marcheselli; Alessia Bari; Tamar Tadmor; Luigi Marcheselli; Maria Christina Cox; Samantha Pozzi; Angela Ferrari; Luca Baldini; Paolo Gobbi; Ariel Aviv; Giuseppe Pugliese; Massimo Federico; Aaron Polliack; Stefano Sacchi
Journal:  Hematol Oncol       Date:  2016-10-28       Impact factor: 5.271

8.  Relationship between Neutrophil-to-Lymphocyte Ratio and Inflammatory Markers in Sickle Cell Anaemia Patients with Proteinuria.

Authors:  Mathias Abiodun Emokpae; Austin Aruomaren; Evarista Osime
Journal:  Med Sci (Basel)       Date:  2016-07-29

9.  Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.

Authors:  Rajendra Gharbaran; Andre Goy; Takemi Tanaka; Jongwhan Park; Chris Kim; Nafis Hasan; Swathi Vemulapalli; Sreeja Sarojini; Madalina Tuluc; Kip Nalley; Pritish Bhattacharyya; Andrew Pecora; K Stephen Suh
Journal:  J Hematol Oncol       Date:  2013-08-29       Impact factor: 17.388

10.  The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis.

Authors:  Tiantong Jiang; Xiurong Ding; Weixing Lu
Journal:  Dis Markers       Date:  2016-03-27       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.